Work with thought leaders and academic experts in cancer immunology

Companies can greatly benefit from collaborating with experts in the field of cancer immunology. These researchers have in-depth knowledge and experience in understanding the complex interactions between the immune system and cancer cells. By working with them, companies can gain valuable insights and develop innovative solutions for cancer diagnosis, treatment, and prevention. They can also help in the development of immunotherapies and personalized medicine approaches. Additionally, academic researchers in cancer immunology can provide access to cutting-edge technologies and resources, as well as facilitate collaborations with other experts and institutions. Overall, partnering with cancer immunology experts can accelerate research and development efforts, improve patient outcomes, and contribute to advancements in the fight against cancer.

Researchers on NotedSource with backgrounds in cancer immunology include Maribel Yazdanifar, Xinyuan Lei, Tanwir Hashem, Todd Giorgio, and Shihao Xu.

Xinyuan Lei

Ph.D. level scientist with hands-on experience in immunology-oncology
Most Relevant Research Expertise
Cancer Immunology
Other Research Expertise (2)
T cell Immunology
Immunology Oncology
About
Key words: Immunology oncology, Ph.D., Research Scientist, Flow cytometry, In vivo experiments, Translational research I'm a Ph.D. candidate trained in immunology and oncology. With 9+ years of research/teaching experience and 5+ years of clinical experience. I had 12 high-impact publications with 445+ citations, also 3 more publications in progress. I'm highly independent and scientifically critical with strong communication/writing skills (trilingual in English, Mandarin Chinese and Cantonese) and collaboration experience. Meanwhile, I took on roles of ad-hoc peer reviewer and editorial board member. Years of lab/clinic training, projects/people managing, troubleshooting and collaboration experience made me very confident of becoming a successful post-phd research scientist and a lifelong science explorer. • Project 1: Developed live-Listeria based, highly-attenuated, oral immunization cancer vaccine. Evaluating the immunogenicity and prophylactic/therapeutic efficacy of Lm vaccines in mice orthotopic colorectal cancer models. First author publication in review. • Project 2: Worked on how mitochondrial dynamics and ER stress regulating tumor antigen presentation and immunogenicity in solid tumors using pre-clinical models with a small molecule inhibitor. Published first author paper on Nature Communications (IF=16.6). PMCID: PMC9259736 • Project 3: Worked on combination of B7-H3 CAR-T therapy and epigenetic therapy to boost the anti-tumor efficacy. Published first author paper on Clinical Cancer Research (IF=13.8). PMCID: PMC8722110 • Project 4: Studying how retinoic acid signaling during T cell priming regulates intestinal CD103+ CD8 TRM cell formation. Published paper on Journal of Experimental Medicine (IF=17.6). PMCID: PMC9960115 • Others: Designed, Conducted, and Participated in projects related to anti PD-1/PD-L1 therapy, non-coding RNAs, cancer biology, molecular biology as an Assistant Mentor and Project Designer. Several publications. EB1a Green card holder. No sponsorship needed. Mobile number: +16312028917 Email: [email protected] I'm currently actively looking for a post-phd industry job with graduation time around February 2025. Please feel free to connect, message me if you're interested! I have a lot to offer! Let's make the world a better place together.

See Full Profile

Example cancer immunology projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on cancer immunology?

Development of novel immunotherapies

Collaborating with a cancer immunology expert can help companies in the pharmaceutical industry develop novel immunotherapies. These therapies harness the power of the immune system to target and destroy cancer cells, offering new treatment options for patients.

Identification of biomarkers for early cancer detection

Academic researchers in cancer immunology can assist companies in the biotechnology sector in identifying biomarkers that can be used for early cancer detection. This can lead to the development of non-invasive diagnostic tests that enable early intervention and improved patient outcomes.

Evaluation of immunotherapy efficacy

Companies developing immunotherapies can collaborate with cancer immunology experts to evaluate the efficacy of their treatments. These researchers can design and conduct preclinical and clinical studies to assess the effectiveness of immunotherapeutic interventions.

Investigation of immune escape mechanisms

Collaborating with academic researchers in cancer immunology can help companies understand the mechanisms by which cancer cells evade the immune system. This knowledge can inform the development of strategies to overcome immune evasion and enhance the effectiveness of cancer treatments.

Development of personalized cancer therapies

Cancer immunology experts can contribute to the development of personalized cancer therapies. By studying the interactions between the immune system and individual tumors, they can identify specific targets for immunotherapy and design personalized treatment approaches tailored to each patient's unique profile.